Combination therapy of biologics with traditional agents in psoriasis
Guenther, L.C.
Skin Therapy Letter 16(6): 1-3
2011
ISSN/ISBN: 1201-5989 PMID: 21833461 Document Number: 655009
Although biologics are very efficacious as monotherapy in patients with psoriasis, combination treatment with traditional systemic and topical therapies may increase the speed of onset and enhance efficacy without significant additional toxicity. In contrast, in psoriatic arthritis, the addition of methotrexate to anti-tumour necrosis factor-alpha therapy does not enhance efficacy in either the skin or joints.
Document emailed within 1 workday
Related Documents
Au, S-Chung.; Madani, A.; Alhaddad, M.; Alkofide, M.; Gottlieb, A.B. 2013: Comparison of the efficacy of biologics versus conventional systemic therapies in the treatment of psoriasis at a comprehensive psoriasis care center Journal of drugs in dermatology: JDD 12(8): 861-866Davis, S.A.; Feldman, S.R. 2013: Combination therapy for psoriasis in the United States Journal of Drugs in Dermatology: Jdd 12(5): 546-550
Del Rosso Do, J.Q. 2006: Combination topical therapy for the treatment of psoriasis Journal of Drugs in Dermatology: Jdd 5(3): 232-234
Strober, B.E.; Clarke, S. 2004: Etanercept for the treatment of psoriasis: combination therapy with other modalities Journal of Drugs in Dermatology: Jdd 3(3): 270-272
Danesh, M.J.; Beroukhim, K.; Nguyen, C.; Levin, E.; Koo, J. 2015: Apremilast and adalimumab: a novel combination therapy for recalcitrant psoriasis Dermatology Online Journal 21(6)
Kircik, L.H. 2017: Psoriasis Is a Chronic Disease: Long Term Efficacy and Safety of new Biologics Is Important Journal of Drugs in Dermatology: Jdd 16(8): S113-S114
Kahn, J.S..; Casseres, R.G..; Her, M.J..; Dumont, N.; Gottlieb, A.B..; Rosmarin, D. 2019: Treatment of Psoriasis With Biologics and Apremilast in Patients With a History of Malignancy: A Retrospective Chart Review Journal of Drugs in Dermatology: Jdd 18(4)
Havnaer, A.; Weinberg, J.M.; Han, G. 2019: Systemic therapies in psoriasis: an update on newly approved and pipeline biologics and oral treatments Cutis 104(2s): 17-20
Saripalli, Y.V.; Gaspari, A.A. 2005: Focus on: biologics that affect therapeutic agents in dermatology Journal of Drugs in Dermatology: Jdd 4(2): 233-245
Bonomo, L.; Abittan, B.J..; Hashim, P.W..; Karki, C.; Mason, M.; Lebwohl, M. 2019: Combination use of Systemic Therapies in Psoriasis: Baseline Characteristics from the Corrona Psoriasis Registry Journal of Drugs in Dermatology: Jdd 18(8): 731-740
Boushey, H.A. 1987: Combination therapy with anticholinergic agents for airflow obstruction Postgraduate Medical Journal 63(Suppl 1): 69-74
Rathod, D.; Weinberg, J.M..; Yamauchi, P.S..; Kircik, L.H..; Wollina, U.; Lotti, T.; Goldust, M. 2019: Successful Treatment of Refractory Plaque-Type Psoriasis and Psoriatic Arthritis With Guselkumab and Adalimumab Combination Therapy: A Case Report Journal of Drugs in Dermatology: Jdd 18(4): 394-396
Van der Vleuten, C.J.; Gerritsen, M.J.; De Jong, E.M.; Elbers, M.; De Jongh, G.J.; van de Kerkhof, P.C. 1996: A novel dithranol formulation (Micanol): the effects of monotherapy and UVB combination therapy on epidermal differentiation, proliferation and cutaneous inflammation in psoriasis vulgaris Acta Dermato-Venereologica 76(5): 387-391
Grujić, M.; Perinović, M.; Rizvanbegović, B. 1976: Oral therapy of diabetes mellitus by combination of hypoglycemic agents Medicinski Arhiv 30(3): 167-171
Jacobs, S.P.; Wodinsky, I.; Kensler, C.J.; Venditti, J.M. 1970: Combination therapy studies with L-asparaginase (NSC-109229) and other antitumor agents Cancer ChemoTherapy Reports 54(5): 329-335
Lui, H.; Gulliver, W.; Tan, J.; Hong, C-Ho.; Hull, P.; Shear, N.H.; Paradiso-Hardy, F.; Bissonette, R. 2012: A randomized controlled study of combination therapy with alefacept and narrow band UVB phototherapy (UVB) for moderate to severe psoriasis: efficacy, onset, and duration of response Journal of Drugs in Dermatology: Jdd 11(8): 929-937
Nightengale, B.S.; Crumly, J.M.; Liao, J.; Lawrence, B.J.; Jacobs, E.W. 1998: Economic outcomes of antipsychotic agents in a Medicaid population: traditional agents vs. risperidone Psychopharmacology Bulletin 34(3): 373-382
Korshunov, S.F. 1987: Rational combination of antibacterial agents in the therapy of acute pneumonias in young children Pediatriia 9: 72-76
Gospavić, J.; Vidaković, Z. 1974: Effectiveness of a combination therapy in the Parkinson syndrome by amantadine hydrochloride and anticholinergic agents Srpski Arhiv Za Celokupno Lekarstvo 102(6): 447-457
Schubert, J. 2005: The use of antidepressive agents in psychotherapy is more and more common. Different views on combination therapy demand further studies Lakartidningen 102(22): 1727-1728; 1730-1731